Skip to Content
Stock Analyst Update

Under Armour Slammed by COVID-19, Recovery Looks Slow

We expect to lower our fair value estimate for the no-moat company after a devastating first quarter.


No-moat Under Armour’s (UA) results for the first quarter of 2020 were even worse than we had feared, and it appears there is little hope of a quick recovery. While Under Armour’s first-quarter sales decline of 23% was just below our forecast of a 22% drop, its adjusted operating loss of $121.7 million was well short of our expectation of a $94.5 million loss. Surprisingly, despite the lower sales, the firm’s selling, general, and administrative expenses jumped 8% on higher marketing and legal costs. We anticipate a decrease in operating expenses in the second quarter as the company has recently furloughed employees, slashed marketing, and taken other steps to conserve cash. Unfortunately, while Under Armour provided no specific guidance, it revealed that second-quarter sales may decline as much as 50%-60%, well below our prior forecast of a 36% decrease. The company is suffering supply disruptions and most of its worldwide stores and those of its wholesale partners remain closed. While its stores in China and South Korea are now open, the company reported sluggish customer traffic. Thus, we expect to reduce our $12.40 fair value estimate on Under Armour per share by a high-single-digit percentage. However, we view shares as attractive for investors willing to look past the near-term turmoil as we do not expect the firm to become distressed.

We believe Under Armour has enough liquidity to get through the crisis. The firm closed the first quarter with $959 million in cash and has since borrowed an additional $100 million under its revolving credit facility, leaving $550 million in remaining borrowing capacity. There was a risk that the firm could violate its debt covenants, given the likelihood of negative EBITDA in 2020. Under Armour, though, reports that it is in the final stages of amending these covenants, so we do not view this as near-term risk.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

David Swartz does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.